Cell-cycle-dependent EBNA1-DNA crosslinking promotes replication termination at oriP and viral episome maintenance

Copyright © 2020 Elsevier Inc. All rights reserved..

Epstein-Barr virus (EBV) is an oncogenic human herpesvirus that persists as a multicopy episome in proliferating host cells. Episome maintenance is strictly dependent on EBNA1, a sequence-specific DNA-binding protein with no known enzymatic activities. Here, we show that EBNA1 forms a cell cycle-dependent DNA crosslink with the EBV origin of plasmid replication oriP. EBNA1 tyrosine 518 (Y518) is essential for crosslinking to oriP and functionally required for episome maintenance and generation of EBV-transformed lymphoblastoid cell lines (LCLs). Mechanistically, Y518 is required for replication fork termination at oriP in vivo and for formation of SDS-resistant complexes in vitro. EBNA1-DNA crosslinking corresponds to single-strand endonuclease activity specific to DNA structures enriched at replication-termination sites, such as 4-way junctions. These findings reveal that EBNA1 forms tyrosine-dependent DNA-protein crosslinks and single-strand cleavage at oriP required for replication termination and viral episome maintenance.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:184

Enthalten in:

Cell - 184(2021), 3 vom: 04. Feb., Seite 643-654.e13

Sprache:

Englisch

Beteiligte Personen:

Dheekollu, Jayaraju [VerfasserIn]
Wiedmer, Andreas [VerfasserIn]
Ayyanathan, Kasirajan [VerfasserIn]
Deakyne, Julianna S [VerfasserIn]
Messick, Troy E [VerfasserIn]
Lieberman, Paul M [VerfasserIn]

Links:

Volltext

Themen:

42HK56048U
Cross-Linking Reagents
DNA, Viral
DNA Adducts
DNA-binding domain
DNA-protein adducts
EBNA1
EBV-encoded nuclear antigen 1
EC 3.1.-
Endonucleases
Episome
Epstein-Barr Virus Nuclear Antigens
Epstein-Barr virus
Herpesvirus
Journal Article
O5GA75RST7
OriP
Plasmid maintenance
RADAR
Research Support, N.I.H., Extramural
Tyrosine
Tyrosine resolvase
Viral latency

Anmerkungen:

Date Completed 24.08.2021

Date Revised 05.02.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.cell.2020.12.022

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM320443124